High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 763-770

  Paris, Pamela L ^a   Albertson, Donna G ^a   Alers, Janneke C ^c   Andaya, Armann ^a   Carroll, Peter ^b   Fridlyand, Jane ^a   Jain, Ajay N ^a   Kamkar, Sherwin ^a   Kowbel, David ^a   Krijtenburg, Pieter Jaap ^c   Pinkel, Daniel ^a   Schröder, Fritz H ^c   Vissers, Kees J ^c   Watson, Vivienne J E ^a   Wildhagen, Mark F ^c   Collins, Colin ^a   Van Dekkent, Herman ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; TUMOR MARKER;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GRADING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA EXTRACTION; DNA MICROARRAY; EMBEDDING; FOLLOW UP; GENE AMPLIFICATION; GENE DELETION; GENETIC LINKAGE; GENOMIC MICROARRAY; HUMAN; HUMAN TISSUE; MALE; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROSTATE TUMOR; QUANTITATIVE GENETICS; QUANTITATIVE MICROSATELLITE ANALYSIS; SCORING SYSTEM; TISSUE FIXATION;

EID: 0037370718     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63873-4     Document Type: Article

References (31)

1. Bepler G, Gautam A, McIntyre LM, Beck AF, Chervinsky DS, Kim YC, Pitterle DM, Hyland A: Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J Clin Oncol 2002, 20:1353-1360
2. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Vihko P: Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behavior of the disease, recurrent growth, poor differentiation of the tumor and poor prognosis for the patient. Br J Cancer 1999, 79:156-160
3. Kressner U, Inganas M, Byding S, Blikstad I, Pahlman L, Glimelius B, Lindmark G: Prognostic value of p53 genetic changes In colorectal cancer. J Clin Oncol 1999, 17:593-599
4. Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC: Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosom Cancer 1997, 19:22-28
5. Pinkel D, Segraves R, Sdar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SH, Ljung B-M, Gray JW, Albertson DG: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-211
6. Wessendorf S, Fritz B, Wrobel G, Nessling M, Lampel S, Goettel D, Kuepper M, Joos S, Hopman T, Kokocinski F, Dohner H, Bentz M, Schwaenen C, Lichter P: Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab Invest 2002, 82:47-60
7. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG: Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001, 29:263-264
8. Daigo Y, Chin SF, Gorringe KL, Bobrow LG, Ponder BA, Pharoah PD, Caldas C: Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for the molecular analysis of paraffin-embedded cancer tissue. Am J Pathol 2001, 158:1623-1631
9. Alers JC, Rochat J, Krijtenburg PJ, Hop WCJ, Kranse R, Rosenberg C, Tanke HJ, Schröder FH, van Dekken H: Identification of genetic markers for prostate cancer progression. Lab Invest 2000, 80:931-942
10. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WCJ, van der Kwast TH, Schröder FH, Tanke HJ, van Dekken H: Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features. Am J Pathol 2001, 158:399-406
11. Hermanek P, Hutter RVP, Sobin LH: TNM Atlas IUAC, ed 4. New York, Springer, 1997
12. Gleason DF: Histologic grading of prostate cancer: a perspective. Hum Pathol 1992, 23:273-279
13. Alers JC, Krijtenburg PJ, Rosenberg C, Hop WCJ, Verkerk AM, Schröder FH, van der Kwast TH, Bosman FT, van Dekken H: Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 1997, 77:437-448
14. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D: Fully automatic quantification of microarray image data. Genome Res 2002, 12:325-332
15. Alers JC, Krijtenburg PJ, Hop WCJ, Bolle WABM, Schröder FH, van der Kwast TH, Bosman FT, van Dekken H: Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours. J Pathol 1998, 185:273-283
16. Alers JC, Rochat J, Krijtenburg PJ, van Dekken H, Raap AK, Rosenberg C: Universal linkage system (ULS): an improved method for labeling archival DNA for comparative genomic hybridization. Genes Chromosom Cancer 1999, 25:301-305
17. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW: Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000, 60:5405-5409
18. Bruder CE, Hirvela C, Tapia-Paez I, Fransson I, Segraves R, Hamilton G, Zhang XX, Evans DG, Wallace AJ, Baser ME, Zucman-Rossi J, Hergersberg M, Boltshauser E, Papi L, Rouleau GA, Poptodorov G, Jordanova A, Rask-Andersen H, Kluwe L, Mautner V, Sainio M, Hung G, Mathiesen T, Moller C, Pulst SM, Harder H, Heiberg A, Honda M, Niimura M, Sahlen S, Blennow E, Albertson DG, Pinkel D, Dumanski JP: High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 2001, 10:271-282
19. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK: Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 2001, 81:717-723
20. Hui AB, Lo KW, Teo PM, To KF, Huang DP: Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 2002, 20:467-473
21. Neville PJ, Conti DV, Paris PL, Levin H, Catalona WJ, Suarez BK, Witte JS, Casey G: Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia 2002, 4:424-431
22. Nupponen NN, Hytinen ER, Kallioniemi AH, Visakorpi T: Genetic alterations in prostate cancer cell lines detected by CGH. Cancer Genet Cytogenet 1998, 101:53-57
23. Fu W, Bubendorf L, Willi N, Moch H, Mihatsch MJ, Sauter G, Gasser TC: Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization. Urology 2000, 56:880-885
24. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Grönberg H, Emanuelsson M, Damber JE, Bergh A, Jonsson BA, Smith J, Bailey-Wilson J, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van Aucken A, Sood R, Collins F, Brownstein M, Trent J: Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998, 20:175-179
25. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R: Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res 1997, 57:1058-1062
26. Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC, Catalona WJ: A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 2000, 66:933-944
27. Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G: Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res 2000, 60:3645-3649
28. Srikantan V, Sesterhenn IA, Davis L, Hankins GR, Avallone FA, Livezey JR, Connelly R, Mostofi FK, McLeod DG, Moul JW, Chandrasekharappa SC, Srivastava S: Allelic loss on chromosome 6q in primary prostate cancer. Int J Cancer 1999, 84:331-335
29. Cher ML. MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH: Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 1994, 11:153-162
30. Perinchery G, Bukurov N, Nakajima K, Chang J, Hooda M, Oh BR, Dahiya R: Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer. Int J Oncol 1999, 14:495-500
31. Haggman MJ, Wojno KJ, Pearsall CP, Macoska JA: Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology 1997, 50:643-647